Topics

UPenn Algorithm Prioritizes Cancer Mutations for Immunotherapy

20:00 EDT 10 Oct 2019 | Cancer Networks

The neoantigens found in the patients’ tumors (non-small-cell lung cancer) which were highly dissimilar were enriched for hydrophobic sequences, and correlated with survival rates after the PD-1 checkpoint therapy.

Original Article: UPenn Algorithm Prioritizes Cancer Mutations for Immunotherapy

NEXT ARTICLE

More From BioPortfolio on "UPenn Algorithm Prioritizes Cancer Mutations for Immunotherapy"

Quick Search

Relevant Topic

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...